Ovral and Drowsiness - a phase IV clinical study of FDA data

Summary:

Drowsiness is reported as a side effect among people who take Ovral (ethinyl estradiol; norgestrel), especially for people who are female, 30-39 old, have been taking the drug for 6 - 12 months also take Xyrem, and have Narcolepsy.

The phase IV clinical study analyzes which people have Drowsiness when taking Ovral. It is created by eHealthMe based on reports of 1,503 people who have side effects when taking Ovral from the FDA, and is updated regularly.

What is Ovral?

Ovral has active ingredients of ethinyl estradiol; norgestrel. It is often used in birth control. eHealthMe is studying from 1,571 Ovral users. Check the latest studies of Ovral.

What is Drowsiness?

Drowsiness is found to be associated with 2,863 drugs and 4,792 conditions by eHealthMe. Check the latest studies of Drowsiness.

On Apr, 25, 2026

1,503 people reported to have side effects when taking Ovral.
Among them, 14 people (0.93%) have Drowsiness.

Among these 14 people:

How long have people been on Ovral when they have Drowsiness? *

What is the gender of people who have Drowsiness when taking Ovral? *

female: 100 %
male: 0.0 %

What is the age of people who have Drowsiness when taking Ovral? *

What are other drugs people take besides Ovral? *

What are other side effects people have besides Drowsiness? *

Depression: 5 people, 35.71%
Hyperhidrosis (abnormally increased sweating): 5 people, 35.71%
Irritability: 4 people, 28.57%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 4 people, 28.57%
Temperature Intolerance (inability to go in temperature): 4 people, 28.57%
Fatigue (feeling of tiredness): 4 people, 28.57%
Tremor (trembling or shaking movements in one or more parts of your body): 3 people, 21.43%
Panic Disorder: 2 people, 14.29%
Chest Pain: 2 people, 14.29%
Cardiac Flutter (abnormal heart rhythm): 2 people, 14.29%

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 7 people, 50.00%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 6 people, 42.86%
Stress And Anxiety: 5 people, 35.71%
Seasonal Allergy (allergic condition due to certain season): 4 people, 28.57%
Panic Disorder: 4 people, 28.57%
Neuralgia (pain in one or more nerves): 4 people, 28.57%
Apathy: 4 people, 28.57%
Vulvovaginal Pain: 1 person, 7.14%
Sleep Disorder: 1 person, 7.14%
Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Ovral and have Drowsiness?

- Check whether Drowsiness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ovral:

Ovral (1,571 reports)

Drowsiness treatments and more:

Drowsiness (269,040 reports)

Browse all side effects of Ovral:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Drowsiness:

Drowsiness (2,863 drugs)

Browse all the conditions that are associated with Drowsiness:

Drowsiness (4,792 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ethinyl estradiol; norgestrel (the active ingredients of Ovral) and Ovral (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.